Kanber Deniz, Woestefeld Julia, Döpper Hannah, Bozet Morgane, Brenzel Alexandra, Altmüller Janine, Kilpert Fabian, Lohmann Dietmar, Pommerenke Claudia, Steenpass Laura
Institute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Eye Oncogenetics Research Group, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Cancers (Basel). 2022 Apr 26;14(9):2166. doi: 10.3390/cancers14092166.
Retinoblastoma is a tumor of the eye in children under the age of five caused by biallelic inactivation of the tumor suppressor gene in maturing retinal cells. Cancer models are essential for understanding tumor development and in preclinical research. Because of the complex organization of the human retina, such models were challenging to develop for retinoblastoma. Here, we present an organoid model based on differentiation of human embryonic stem cells into neural retina after inactivation of by CRISPR/Cas9 mutagenesis. Wildtype and heterozygous mutant retinal organoids were indistinguishable with respect to morphology, temporal development of retinal cell types and global mRNA expression. However, loss of pRB resulted in spatially disorganized organoids and aberrant differentiation, indicated by disintegration of organoids beyond day 130 of differentiation and depletion of most retinal cell types. Only cone photoreceptors were abundant and continued to proliferate, supporting these as candidate cells-of-origin for retinoblastoma. Transcriptome analysis of knockout organoids and primary retinoblastoma revealed gain of a retinoblastoma expression signature in the organoids, characterized by upregulation of (p107), , , and . In addition, genes related to immune response and extracellular matrix were specifically upregulated in -negative organoids. In vitro retinal organoids therefore display some features associated with retinoblastoma and, so far, represent the only valid human cancer model for the development of this disease.
视网膜母细胞瘤是一种发生于5岁以下儿童眼部的肿瘤,由成熟视网膜细胞中肿瘤抑制基因的双等位基因失活引起。癌症模型对于理解肿瘤发展和临床前研究至关重要。由于人类视网膜组织结构复杂,开发视网膜母细胞瘤的此类模型具有挑战性。在此,我们展示了一种基于人胚胎干细胞经CRISPR/Cas9诱变失活后分化为神经视网膜的类器官模型。野生型和杂合突变型视网膜类器官在形态、视网膜细胞类型的时间发育和整体mRNA表达方面并无差异。然而,RB蛋白的缺失导致类器官空间结构紊乱和异常分化,表现为分化130天后类器官解体以及大多数视网膜细胞类型减少。只有视锥光感受器数量丰富且持续增殖,支持其作为视网膜母细胞瘤的候选起源细胞。对RB基因敲除类器官和原发性视网膜母细胞瘤的转录组分析显示,类器官中出现了视网膜母细胞瘤表达特征,其特点是E2F3(p107)、E2F5、MYCN、CCND2和MCM2上调。此外,与免疫反应和细胞外基质相关的基因在RB阴性类器官中特异性上调。因此,体外视网膜类器官表现出一些与视网膜母细胞瘤相关的特征,并且是目前唯一用于该疾病研究的有效人类癌症模型。